IndiumV2, Main, Exploration, bibRecord, 001602

Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.

Identifieur interne : 001602 ( Main/Exploration ); précédent : 001601; suivant : 001603

Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.

Auteurs : RBID : pubmed:21555687

English descriptors

KwdEn :
- Adult, Disease Progression, Female, Humans, Indium Radioisotopes (therapeutic use), Intestinal Neoplasms (radiotherapy), Intestinal Neoplasms (surgery), Liver Neoplasms (radiotherapy), Liver Neoplasms (secondary), Lymphatic Metastasis (radiotherapy), Magnetic Resonance Imaging (methods), Neoplasm Metastasis, Neuroendocrine Tumors (radiotherapy), Neuroendocrine Tumors (surgery), Octreotide (analogs & derivatives), Octreotide (therapeutic use), Positron-Emission Tomography (methods), Radioisotopes (therapeutic use), Receptors, Peptide (drug effects), Somatostatin (pharmacokinetics), Tomography, X-Ray Computed (methods), Yttrium Radioisotopes (therapeutic use).
MESH :
- chemical , analogs & derivatives : Octreotide.
- chemical , drug effects : Receptors, Peptide.
- chemical , pharmacokinetics : Somatostatin.
- chemical , therapeutic use : Indium Radioisotopes, Octreotide, Radioisotopes, Yttrium Radioisotopes.
- methods : Magnetic Resonance Imaging, Positron-Emission Tomography, Tomography, X-Ray Computed.
- radiotherapy : Intestinal Neoplasms, Liver Neoplasms, Lymphatic Metastasis, Neuroendocrine Tumors.
- secondary : Liver Neoplasms.
- surgery : Intestinal Neoplasms, Neuroendocrine Tumors.
- Adult, Disease Progression, Female, Humans, Neoplasm Metastasis.

DOI: 10.1200/JCO.2010.34.3384
PubMed: 21555687

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001384
to stream Main, to step Curation: 001384

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.</title>
<author><name sortKey="Van Binnebeek, Sofie" uniqKey="Van Binnebeek S">Sofie Van Binnebeek</name>
<affiliation wicri:level="1"><nlm:affiliation>University Hospital Leuven, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>University Hospital Leuven, Leuven</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Deroose, Christophe M" uniqKey="Deroose C">Christophe M Deroose</name>
</author>
<author><name sortKey="Baete, Kristof" uniqKey="Baete K">Kristof Baete</name>
</author>
<author><name sortKey="Terwinghe, Christelle" uniqKey="Terwinghe C">Christelle Terwinghe</name>
</author>
<author><name sortKey="Vanbilloen, Bert" uniqKey="Vanbilloen B">Bert Vanbilloen</name>
</author>
<author><name sortKey="Koole, Michel" uniqKey="Koole M">Michel Koole</name>
</author>
<author><name sortKey="Haustermans, Karin" uniqKey="Haustermans K">Karin Haustermans</name>
</author>
<author><name sortKey="Mortelmans, Luc" uniqKey="Mortelmans L">Luc Mortelmans</name>
</author>
<author><name sortKey="Verslype, Chris" uniqKey="Verslype C">Chris Verslype</name>
</author>
<author><name sortKey="Van Cutsem, Eric" uniqKey="Van Cutsem E">Eric Van Cutsem</name>
</author>
<author><name sortKey="Verbruggen, Alfons" uniqKey="Verbruggen A">Alfons Verbruggen</name>
</author>
<author><name sortKey="Mottaghy, Felix M" uniqKey="Mottaghy F">Felix M Mottaghy</name>
</author>
</titleStmt>
<publicationStmt><date when="2011">2011</date>
<idno type="doi">10.1200/JCO.2010.34.3384</idno>
<idno type="RBID">pubmed:21555687</idno>
<idno type="pmid">21555687</idno>
<idno type="wicri:Area/Main/Corpus">001384</idno>
<idno type="wicri:Area/Main/Curation">001384</idno>
<idno type="wicri:Area/Main/Exploration">001602</idno>
</publicationStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Indium Radioisotopes (therapeutic use)</term>
<term>Intestinal Neoplasms (radiotherapy)</term>
<term>Intestinal Neoplasms (surgery)</term>
<term>Liver Neoplasms (radiotherapy)</term>
<term>Liver Neoplasms (secondary)</term>
<term>Lymphatic Metastasis (radiotherapy)</term>
<term>Magnetic Resonance Imaging (methods)</term>
<term>Neoplasm Metastasis</term>
<term>Neuroendocrine Tumors (radiotherapy)</term>
<term>Neuroendocrine Tumors (surgery)</term>
<term>Octreotide (analogs & derivatives)</term>
<term>Octreotide (therapeutic use)</term>
<term>Positron-Emission Tomography (methods)</term>
<term>Radioisotopes (therapeutic use)</term>
<term>Receptors, Peptide (drug effects)</term>
<term>Somatostatin (pharmacokinetics)</term>
<term>Tomography, X-Ray Computed (methods)</term>
<term>Yttrium Radioisotopes (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Octreotide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Peptide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Somatostatin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Indium Radioisotopes</term>
<term>Octreotide</term>
<term>Radioisotopes</term>
<term>Yttrium Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetic Resonance Imaging</term>
<term>Positron-Emission Tomography</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Intestinal Neoplasms</term>
<term>Liver Neoplasms</term>
<term>Lymphatic Metastasis</term>
<term>Neuroendocrine Tumors</term>
</keywords>
<keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Liver Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Intestinal Neoplasms</term>
<term>Neuroendocrine Tumors</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Neoplasm Metastasis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">21555687</PMID>
<DateCreated><Year>2011</Year>
<Month>06</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>09</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-7755</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>29</Volume>
<Issue>19</Issue>
<PubDate><Year>2011</Year>
<Month>Jul</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</Title>
<ISOAbbreviation>J. Clin. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.</ArticleTitle>
<Pagination><MedlinePgn>e579-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1200/JCO.2010.34.3384</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Binnebeek</LastName>
<ForeName>Sofie</ForeName>
<Initials>S</Initials>
<Affiliation>University Hospital Leuven, Leuven, Belgium.</Affiliation>
</Author>
<Author ValidYN="Y"><LastName>Deroose</LastName>
<ForeName>Christophe M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Baete</LastName>
<ForeName>Kristof</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Terwinghe</LastName>
<ForeName>Christelle</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vanbilloen</LastName>
<ForeName>Bert</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Koole</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Haustermans</LastName>
<ForeName>Karin</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mortelmans</LastName>
<ForeName>Luc</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Verslype</LastName>
<ForeName>Chris</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Van Cutsem</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Verbruggen</LastName>
<ForeName>Alfons</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mottaghy</LastName>
<ForeName>Felix M</ForeName>
<Initials>FM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>05</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Clin Oncol</MedlineTA>
<NlmUniqueID>8309333</NlmUniqueID>
<ISSNLinking>0732-183X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Indium Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Peptide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Yttrium Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>51110-01-1</RegistryNumber>
<NameOfSubstance>Somatostatin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>RWM8CCW8GP</RegistryNumber>
<NameOfSubstance>Octreotide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>U194AS08HZ</RegistryNumber>
<NameOfSubstance>Edotreotide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Intestinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName MajorTopicYN="N">secondary</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
<QualifierName MajorTopicYN="N">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Neuroendocrine Tumors</DescriptorName>
<QualifierName MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Octreotide</DescriptorName>
<QualifierName MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Receptors, Peptide</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Somatostatin</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Yttrium Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="aheadofprint"><Year>2011</Year>
<Month>5</Month>
<Day>9</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>5</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>5</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>9</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">JCO.2010.34.3384</ArticleId>
<ArticleId IdType="doi">10.1200/JCO.2010.34.3384</ArticleId>
<ArticleId IdType="pubmed">21555687</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001602 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001602 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21555687
   |texte=   Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21555687" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a IndiumV2

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024

	Serveur d'exploration sur l'Indium
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'Indium

Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.

Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki